NCT04343638View on ClinicalTrials.gov

Effect of Intraoperative Nociception Control Based on Analgesia Nociception Index (ANI) Monitoring on Stress Response During Total Laparoscopic Hysterectomy

NACompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

May 8, 2020

Primary Completion Date

October 28, 2021

Study Completion Date

October 28, 2021

Conditions
Patients Undergoing Total Laparoscopic Hysterectomy
Interventions
DEVICE

conventional nociception control

While Intraoperative opioid will be administered by conventional clinical practice in control arm.

DEVICE

ANI monitor guided nociception control

The intraoperative opioid will be administered by maintaining the 4-minute moving average of ANI ≥50 in ANI-monitor guided nociception control arm.

Trial Locations (1)

Unknown

Department of Anesthesiology and Pain Medicine, Severance Hospital, Seoul

All Listed Sponsors
lead

Yonsei University

OTHER

NCT04343638 - Effect of Intraoperative Nociception Control Based on Analgesia Nociception Index (ANI) Monitoring on Stress Response During Total Laparoscopic Hysterectomy | Biotech Hunter | Biotech Hunter